Question
Are older antiviral drugs beneficial for adults hospitalized with COVID-19?
Conclusion
This large open-label randomized trial found no benefit to remdesivir, interferon, lopinavir, or hydroxychloroquine for adults hospitalized with COVID-19. The only possible benefit was seen with remdesivir in patients who required low-flow or no oxygen, but the absolute benefit, if any, was small.
Recent Posts
- Twice-daily low-dose aspirin is similar to enoxaparin for thromboprophylaxis after inpatient treatment for fracture (PREVENT CLOT)
- 90% of ankle arthroplasties last 5 years
- Vitamin D supplementation slightly reduces diabetes diagnoses in at-risk adults
- Surgery is no better than nonoperative treatment for Achilles tendon rupture in adults
- Another study fails to find PRP injections effective for adults with degenerative joint disease of the knee
Leave A Comment